Peptide Therapeutics for the Treatment of Autoimmune Diseases: Stability, Delivery and Disposition

Project: Research

Status	Finished
Effective start/end date	1/01/15 → 30/09/17

Distribution and kinetics of the Kv1.3-blocking peptide HsTX1[R14A] in experimental rats
Bergmann, R., Kubeil, M., Zarschler, K., Chhabra, S., Tajhya, R. B., Beeton, C., Pennington, M. W., Bachmann, M. H., Norton, R. S. & Stephan, H., 1 Dec 2017, In: Scientific Reports. 7, 1, 11 p., 3756.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

18 Citations (Scopus)
Enhancing the therapeutic potential of peptide toxins
Norton, R. S., 3 Jun 2017, In: Expert Opinion on Drug Discovery. 12, 6, p. 611-623 13 p.
Research output: Contribution to journal › Review Article › Research › peer-review

42 Citations (Scopus)
Pulmonary delivery of the Kv1.3-blocking peptide HsTX1[R14A] for the treatment of autoimmune diseases
Jin, L., Zhou, Q., Chan, H-K., Larson, I. C., Pennington, M. W., Morales, R. A. V., Boyd, B. J., Norton, R. S. & Nicolazzo, J. A., 1 Feb 2016, In: Journal of Pharmaceutical Sciences. 105, 2, p. 650-656 7 p.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

31 Citations (Scopus)

Project Details